Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors inside the central anxious procedure, conolidine modulates alternate molecular targets. A Science Advances review located that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://edwiniolgb.blogitright.com/37812789/not-known-factual-statements-about-alternative-natural-pain-relief-to-replace-traditional-painkillers